Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Iovance Biotherapeutics Inc (NQ: IOVA ) 10.35 +0.18 (+1.77%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 3,938,579 Open 10.60 Bid (Size) 10.34 (1) Ask (Size) 10.41 (2) Prev. Close 10.17 Today's Range 10.29 - 10.71 52wk Range 3.210 - 18.33 Shares Outstanding 303,513,872 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 3 Things You Need to Know if You Buy Iovance Biotherapeutics Today September 16, 2024 There's plenty of upside with this stock, but it might take a while to realize. Via The Motley Fool AST SpaceMobile And Polestar Automotive Are Among Top 10 Best Performing Mid-Cap Stocks in August: Are The Others In Your Portfolio? September 08, 2024 The top 10 mid-cap stocks in August: Polestar Automotive, Upstart, Lumen Technologies, GDS Holdings, Tempus AI, Clear Secure, Iovance Biotherapeutics, Evolent Health, Semtech Corp, AST SpaceMobile. Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Performance YTD +27.78% +27.78% 1 Month -7.51% -7.51% 3 Month +29.86% +29.86% 6 Month -30.68% -30.68% 1 Year +90.61% +90.61% More News Read More This Is the Biggest Risk With Iovance Biotherapeutics Stock September 06, 2024 Via The Motley Fool Iovance Biotherapeutics to Present at Upcoming Conferences September 03, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire (IOVA) - Analyzing Iovance Biotherapeutics's Short Interest September 03, 2024 Via Benzinga Looking Into Iovance Biotherapeutics's Recent Short Interest August 16, 2024 Via Benzinga Iovance Biotherapeutics Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) August 12, 2024 Via Benzinga What the Options Market Tells Us About Iovance Biotherapeutics August 08, 2024 Via Benzinga 3 Monster Biotech Stocks to Buy Before 2025 September 02, 2024 Via The Motley Fool Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years? August 27, 2024 Via The Motley Fool Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) August 16, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire This 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock August 14, 2024 Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session August 12, 2024 Via Benzinga Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday August 09, 2024 Via Benzinga Why Iovance Biotherapeutics Shares Are Soaring Today August 09, 2024 Via The Motley Fool Why Is Iovance Bio (IOVA) Stock Up 18% Today? August 09, 2024 Via InvestorPlace Topics Earnings Exposures Financial Skin Cancer-Focused Iovance Biotherapeutics Reports Better-Than-Expected 2024, 2025 Outlook, Stock Surges August 09, 2024 Via Benzinga Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket August 09, 2024 Via Benzinga IOVA Stock Earnings: Iovance Biotherapeutics Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 Via InvestorPlace Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024 August 08, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire 10 Best Small and Mid-Cap Stocks to Consider Buying in August August 01, 2024 Via The Motley Fool Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell? July 31, 2024 Via The Motley Fool Why Iovance Biotherapeutics Stock Stumbled Today July 29, 2024 Via The Motley Fool Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024 July 29, 2024 From Iovance Biotherapeutics, Inc. Via GlobeNewswire Iovance Biotherapeutics Price Forecast Slashed By 40% On Mutated Uptake For Its Newly Approved Skin Cancer Cell Therapy July 29, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.